Kalytera Announces Extension of Maturity Date of Promissory Note
SAN FRANCISCO and TEL AVIV, Israel , March 16, 2020 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") announced today that, in connection with the Company's previously …